磁共振成像在前列腺癌中的应用研究进展
摘要
<正>前列腺癌(PCA)是男性中第二常见的癌症类型,也是全球范围内第五大癌症的相关死亡原因~([1])。其也是84个国家男性中最常见的癌症,在发达国家发病率更高,在发展中国家的发病率也在逐渐上升~([2])。PCA给患者带来了沉重的负担和极大的痛苦,严重影响了患者的生活质量。大多数PCA生长速度较缓慢,但有些PCA生长相对较快。早期诊断和分期对
引文
[1]MCGUIRE S.World Cancer Report 2014.Geneva,Switzerland:World Health Organization,International Agency for Research on Cancer,WHO Press,2015[J].Advan Nutri(Bethesda,Md),2016,7(2):418-419.
[2]BAADE PD,YOULDEN DR,KRNJACKI LJ.International epidemiology of prostate cancer geographical distribution and secular trends[J].Mol Nutri Food Res,2009,53(2):171-184.
[3]GRAHAM J,KIRKRIDE P,CANN K,et al.Prostate cancer:summary of updated NICE guidance[J].BMJ,2014,348:f7524.
[4]DELONGCHAMPS NB,ROUANNE M,FLAM T,et al.Multiparametricmagnetic resonanceimaging for the detection and localization of prostate cancer:combination of T2-weighted,dynamic contrast-enhancedand diffusion-weighted imaging[J].BJU Int,2011,107(9):1411-1418.
[5]GüRSES B,TASDELEN N,YENCILEK F,et al.Diagnostic utility of DTI in prostate cancer[J].Eur J Radiol,2011,79(2):172-176.
[6]XU J,HUMPHREY PA,KIBEL AS,et al.Magnetic resonance diffusion characteristic of histologically defined prostate cancer in humans[J].Magn Reson Med,2009,61(4):842-850.
[7]周洁,史长征,王永安,等.MRI弥散张量成像对前列腺疾病的诊断价值[J].暨南大学学报(医学版),2011,32(2):233-237.
[8]YACI AB,OZARI N,AYBEK Z,et al.The value of diffusionweighted MRI for prostate cancer detection and localization[J].Diagn Interv Radiol,2011,17(2):130-134.
[9]DE SOUZA NM,RICHES SF,VANAS NJ,et al.Diffusionweighted magnetic resonance imaging:apotential non-invasive marker of tumor aggressiveness in localized prostate cancer[J].Clin Radiol,2008,63(7):774-782.
[10]TAKAYAMA Y,KISHIMOTO R,HANAOKA S,et al.ADCvalue and diffusion tensor imaging of prostate cancer changes in carbonion radiotherapy[J].J Magn Reson Imaging,2008,27(6):1331-1335.
[11]虞丹萍,许顺良,赵新湘,等.DTI对常见前列腺疾病诊断价值的研究[J].临床放射学杂志,2013,32(9):1296-1299.
[12]MANENTI G,CARLANI M,MANCINO S,et al.Diffusion tensor magnetic resonance imaging of prostate cancer[J].Invest Radiol,2007,42(6):412-419.
[13]王霄英,周良平,丁建平,等.MRS对中国人PCA鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153.
[14]SHUKLA-DAVE A,H RICAK H,EB ERHARDT SC,et al.Chronic prostatitis:MR imaging and H1 MR spectroscopic imaging findings initial observations[J].Radiology,2004,231(3):717-724.
[15]YAMAMURA J,SALOMON G,BUCHERT R,et al.MR imaging of prostate cancer:diffusion weightedImaging and(3D)hydrogen(1H)MR spectroscopy in comparison with histology[J].Radiol Res Pract,2011,2011:616852.
[16]MAZAHERI Y,SHUKLA-DAVE A,HRICAK H,et al.Prostatecancer:identification with combined diffusion-weighted MR imaging and 3D1H MR spectroscopicimaging:correlation with pathologic findings[J].Radiology,2008,246(2):480-488.
[17]平小夏,王希明,孟倩,等.3.0TDCE-MRI在前列腺癌诊断中的应用价值[J].实用放射性杂志,2017,33(2):244-247.
[18]王振强,王冬梅,朱艳丽,等.DCE-MRI和DWI在前列腺癌临床诊断与PSA表达的相关性分析[J].浙江临床医学,2017,19(4):633-635.
[19]黄云海,郭咏梅,徐宏刚,等.磁共振动态增强TIC曲线及K~(trans)值在前列腺癌诊断中的对比[J].放射学实践,2016,31(6):511-515.
[20]ALONZI R,PADHANI AR,TAYLOR NJ,et al.Antivascular effects of neoadjuvant androgen deprivation for prostate cancer:an in vivo human study using susceptibility and relaxivity dynamic MRI[J].Int J Radiat Oncol Biol Phys,2011,80:721-727.
[21]BARENTSZ JO,RICHENBERG J,CLEMENTS R,et al.(2012)ESUR prostateMR guidelines 2012[J].Eur Radiol,2012,22:746-757.
[22]BAADE PD,YOULDEN DR,KRNJACKI LJ.International epidemiology of prostate cancer geographical distribution and secular trends[J].Mol Nutri Food Res,2009,53(2):171-184.
[23]HEIDENREICH A,BASTIAN PJ,BELLMUNT J,et al.EAUguidelines on prostate cancer.Part 1:screening,diagnosis,and local treatment with curative intent-update 2013[J].Eur Urol,2014,65(1):124-137.
[24]WRIGHT JL,SALINAS CA,LIN DW,et al.Prostate cancer specific mortality and Gleason 7disease differences in prostate cancer outcomes between cases with Gleason 4+3and Gleason 3+4tumors in a population based cohort[J].J Urol,2009,182(6):2702-2707.
[25]BJURLIN MA,WYSOCK JS,TANEJA SS.Optimization of prostate biopsy:review of technique and complications[J].Urol Clin North Am,2014,41(2):299-313.
[26]TURKBEY B,MANI H,AARAS O,et al.Prostate cancer:can multiparemetric MR imaging help identify patients who are candidates for active surveillance[J].Radiology,2013,268(1):144-152.
[27]LAMBIN P,RIOS-VELAZQUEZ E,LEIJENAAR R,et al.Ra-综述diomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.
[28]GILLIES RJ,KINAHAN PE,HRICAK H.Radiomics:images are more than pictures,they are data[J].Radiology,2016,278(2):563-577.
[29]DONG Y,FENG Q,YANG W,et al.Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI[J].Eur Radiol,2018,28(2):582-591.
[30]SMITS M,VAN DEN BENT MJ.Imaging correlates of adult glioma genotypes[J].Radiology,2017,284(2):316-331.
[31]TIAN Q,YAN LF,ZHANG X,et al.Radiomics strategy for glioma grading using texture features from multiparametric MRI[J].J Magn Reson Imag:JMRI,2018,213:117-128.
[32]WANG J,WU CJ,BAO ML,et al.Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2in clinically relevant prostate cancer[J].Eur Radiol,2017,27(10):4082-4090.
[2]BAADE PD,YOULDEN DR,KRNJACKI LJ.International epidemiology of prostate cancer geographical distribution and secular trends[J].Mol Nutri Food Res,2009,53(2):171-184.
[3]GRAHAM J,KIRKRIDE P,CANN K,et al.Prostate cancer:summary of updated NICE guidance[J].BMJ,2014,348:f7524.
[4]DELONGCHAMPS NB,ROUANNE M,FLAM T,et al.Multiparametricmagnetic resonanceimaging for the detection and localization of prostate cancer:combination of T2-weighted,dynamic contrast-enhancedand diffusion-weighted imaging[J].BJU Int,2011,107(9):1411-1418.
[5]GüRSES B,TASDELEN N,YENCILEK F,et al.Diagnostic utility of DTI in prostate cancer[J].Eur J Radiol,2011,79(2):172-176.
[6]XU J,HUMPHREY PA,KIBEL AS,et al.Magnetic resonance diffusion characteristic of histologically defined prostate cancer in humans[J].Magn Reson Med,2009,61(4):842-850.
[7]周洁,史长征,王永安,等.MRI弥散张量成像对前列腺疾病的诊断价值[J].暨南大学学报(医学版),2011,32(2):233-237.
[8]YACI AB,OZARI N,AYBEK Z,et al.The value of diffusionweighted MRI for prostate cancer detection and localization[J].Diagn Interv Radiol,2011,17(2):130-134.
[9]DE SOUZA NM,RICHES SF,VANAS NJ,et al.Diffusionweighted magnetic resonance imaging:apotential non-invasive marker of tumor aggressiveness in localized prostate cancer[J].Clin Radiol,2008,63(7):774-782.
[10]TAKAYAMA Y,KISHIMOTO R,HANAOKA S,et al.ADCvalue and diffusion tensor imaging of prostate cancer changes in carbonion radiotherapy[J].J Magn Reson Imaging,2008,27(6):1331-1335.
[11]虞丹萍,许顺良,赵新湘,等.DTI对常见前列腺疾病诊断价值的研究[J].临床放射学杂志,2013,32(9):1296-1299.
[12]MANENTI G,CARLANI M,MANCINO S,et al.Diffusion tensor magnetic resonance imaging of prostate cancer[J].Invest Radiol,2007,42(6):412-419.
[13]王霄英,周良平,丁建平,等.MRS对中国人PCA鉴别诊断标准的初步研究[J].中国医学影像技术,2004,20(8):1150-1153.
[14]SHUKLA-DAVE A,H RICAK H,EB ERHARDT SC,et al.Chronic prostatitis:MR imaging and H1 MR spectroscopic imaging findings initial observations[J].Radiology,2004,231(3):717-724.
[15]YAMAMURA J,SALOMON G,BUCHERT R,et al.MR imaging of prostate cancer:diffusion weightedImaging and(3D)hydrogen(1H)MR spectroscopy in comparison with histology[J].Radiol Res Pract,2011,2011:616852.
[16]MAZAHERI Y,SHUKLA-DAVE A,HRICAK H,et al.Prostatecancer:identification with combined diffusion-weighted MR imaging and 3D1H MR spectroscopicimaging:correlation with pathologic findings[J].Radiology,2008,246(2):480-488.
[17]平小夏,王希明,孟倩,等.3.0TDCE-MRI在前列腺癌诊断中的应用价值[J].实用放射性杂志,2017,33(2):244-247.
[18]王振强,王冬梅,朱艳丽,等.DCE-MRI和DWI在前列腺癌临床诊断与PSA表达的相关性分析[J].浙江临床医学,2017,19(4):633-635.
[19]黄云海,郭咏梅,徐宏刚,等.磁共振动态增强TIC曲线及K~(trans)值在前列腺癌诊断中的对比[J].放射学实践,2016,31(6):511-515.
[20]ALONZI R,PADHANI AR,TAYLOR NJ,et al.Antivascular effects of neoadjuvant androgen deprivation for prostate cancer:an in vivo human study using susceptibility and relaxivity dynamic MRI[J].Int J Radiat Oncol Biol Phys,2011,80:721-727.
[21]BARENTSZ JO,RICHENBERG J,CLEMENTS R,et al.(2012)ESUR prostateMR guidelines 2012[J].Eur Radiol,2012,22:746-757.
[22]BAADE PD,YOULDEN DR,KRNJACKI LJ.International epidemiology of prostate cancer geographical distribution and secular trends[J].Mol Nutri Food Res,2009,53(2):171-184.
[23]HEIDENREICH A,BASTIAN PJ,BELLMUNT J,et al.EAUguidelines on prostate cancer.Part 1:screening,diagnosis,and local treatment with curative intent-update 2013[J].Eur Urol,2014,65(1):124-137.
[24]WRIGHT JL,SALINAS CA,LIN DW,et al.Prostate cancer specific mortality and Gleason 7disease differences in prostate cancer outcomes between cases with Gleason 4+3and Gleason 3+4tumors in a population based cohort[J].J Urol,2009,182(6):2702-2707.
[25]BJURLIN MA,WYSOCK JS,TANEJA SS.Optimization of prostate biopsy:review of technique and complications[J].Urol Clin North Am,2014,41(2):299-313.
[26]TURKBEY B,MANI H,AARAS O,et al.Prostate cancer:can multiparemetric MR imaging help identify patients who are candidates for active surveillance[J].Radiology,2013,268(1):144-152.
[27]LAMBIN P,RIOS-VELAZQUEZ E,LEIJENAAR R,et al.Ra-综述diomics:extracting more information from medical images using advanced feature analysis[J].Eur J Cancer,2012,48(4):441-446.
[28]GILLIES RJ,KINAHAN PE,HRICAK H.Radiomics:images are more than pictures,they are data[J].Radiology,2016,278(2):563-577.
[29]DONG Y,FENG Q,YANG W,et al.Preoperative prediction of sentinel lymph node metastasis in breast cancer based on radiomics of T2-weighted fat-suppression and diffusion-weighted MRI[J].Eur Radiol,2018,28(2):582-591.
[30]SMITS M,VAN DEN BENT MJ.Imaging correlates of adult glioma genotypes[J].Radiology,2017,284(2):316-331.
[31]TIAN Q,YAN LF,ZHANG X,et al.Radiomics strategy for glioma grading using texture features from multiparametric MRI[J].J Magn Reson Imag:JMRI,2018,213:117-128.
[32]WANG J,WU CJ,BAO ML,et al.Machine learning-based analysis of MR radiomics can help to improve the diagnostic performance of PI-RADS v2in clinically relevant prostate cancer[J].Eur Radiol,2017,27(10):4082-4090.